Carregant...

Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells

PURPOSE: Polo-like kinase 4 (PLK4) inhibitors, such as CFI-400945 and centrinone, are emerging as promising antineoplastic agents. However, their effectiveness against Ewing’s sarcoma, a highly aggressive childhood cancer, remains to be established. METHODS: CFI-400945 and centrinone were tested in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer Res Clin Oncol
Autors principals: Kerschner-Morales, Sophie L., Kühne, Marie, Becker, Sabine, Beck, James F., Sonnemann, Jürgen
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519924/
https://ncbi.nlm.nih.gov/pubmed/32770382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-020-03346-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!